| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/04/2002 | EP1235575A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property |
| 09/04/2002 | EP1235572A2 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
| 09/04/2002 | EP1150974B1 Heterocyclic derivatives as inhibitors of factor xa |
| 09/04/2002 | EP1080086B1 Dihydropyrimidines |
| 09/04/2002 | EP0966444B1 Process for preparing pyrazole derivatives |
| 09/04/2002 | EP0944672B1 Helium-neon excitable reticulocyte dyes derivable from halolepidines |
| 09/04/2002 | EP0902785B1 Processes and intermediates for preparing 4'-trifluoromethylbiphenyl-2-carboxylic acid 2-(2h- 1,2,4]triazol-3-ylmethyl)-1,2,3,4-tetrahydro-isoquinolin-6-yl]-amide |
| 09/04/2002 | EP0830348B1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 09/04/2002 | EP0642506B1 Heterocyclically bisubstituted sulphonyl amino(thio)carbonyl compounds |
| 09/04/2002 | CN1367778A Novel carboxylic acid derivatives with 5,6 substitutedpyrimidine ring, their production and utilization thereof as endothelin receptor antagonists |
| 09/04/2002 | CN1367695A Phthalazine derivatives for treating inflammatory diseases |
| 09/04/2002 | CN1367678A Method of treating hair loss using ketoamides |
| 09/04/2002 | CN1367172A Prearation method of [(substituted pyridyl) methyl] sulfinyl-IH-benzimidazole compound magnesium salt |
| 09/04/2002 | CN1090187C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090186C HIV protease inhibitors in pharmaceutical combinations for treatment of AIDS |
| 09/04/2002 | CN1090185C Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate thereof |
| 09/03/2002 | USRE37828 Treatment and prevention of adhesions |
| 09/03/2002 | US6444829 (2s,4r)-4-mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carboxylic acid n'-isobutyl-n'-(4-methyl-benzenesulfonyl)-hydrazide, for example; inhibitors of metalloproteases, e.g. zinc proteases; vasodilators |
| 09/03/2002 | US6444823 Pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 09/03/2002 | US6444819 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands |
| 09/03/2002 | US6444817 Anticoagulants |
| 09/03/2002 | US6444812 Intermediate compounds in the preparation of farnnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N-or C linked imidazoles |
| 09/03/2002 | US6444811 Central nervous system disorders; cardiovascular disorders |
| 09/03/2002 | US6444809 Antihistamines |
| 09/03/2002 | US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 09/03/2002 | US6444694 Styryl benzimidazole derivatives |
| 09/03/2002 | US6444689 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 09/03/2002 | US6444687 Eating disorders and diabetes |
| 09/03/2002 | US6444686 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 09/03/2002 | US6444685 N-(4-sulfonylaryl)Cyclylamine 2-hydroxyethylamines as beta-3 adrenergic receptor agonists |
| 09/03/2002 | US6444684 Lavendamycin analogs, quinoline-5,8-diones and methods of using them |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444675 Promoting weight loss and treating eating disorders |
| 09/03/2002 | US6444674 High affinity for the dopamine d3 receptor; schizophrenia, depression, neuroses and psychoses |
| 09/03/2002 | US6444672 Heterocyclic derivatives and their use as antithrombotic agents |
| 09/03/2002 | US6444612 Use of 5-amino-pyrazol-derivatives for combating micro-organisms |
| 09/03/2002 | CA2252621C Processes and intermediates for preparing 4'-trifluoromethylbiphenyl-2-carboxylic acid ¬2-(2h-¬1,2,4|triazol-3-ylmethyl)-1,2,3,4-tetrahydro-isoquinolin-6-yl|-amide |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 09/03/2002 | CA2234051C Novel isoquinoline derivatives |
| 09/01/2002 | CA2373578A1 .beta.3, agonists and uses thereof |
| 08/29/2002 | WO2002066470A1 Substituted alkylamine derivatives and methods of use |
| 08/29/2002 | WO2002066462A1 Pyrazole derivatives against tgf overexpression |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066460A1 Chemical compounds |
| 08/29/2002 | WO2002066459A1 Indole derivatives and their use as gnrh antagonists |
| 08/29/2002 | WO2002066458A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/29/2002 | WO2002066447A1 4h-1,2,4-triazole-3(2h)-thione deratives as sphingomyelinase inhibitors |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066445A1 Quinazoline derivatives |
| 08/29/2002 | WO2002066443A2 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives |
| 08/29/2002 | WO2002066440A1 Diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres |
| 08/29/2002 | WO2002066434A1 Oxime ether compound and agricultural or horticultural bactericide |
| 08/29/2002 | WO2002065979A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 08/29/2002 | WO2002065977A2 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 08/29/2002 | WO2002055516A3 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a) |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 08/29/2002 | WO2002037937A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002026718A3 Bicyclic pyrimidin-4-one based inhibitors of factor xa |
| 08/29/2002 | WO2002002525A3 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 08/29/2002 | WO2002000622A3 Aminoalcohol derivatives |
| 08/29/2002 | WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists |
| 08/29/2002 | WO2001087288A8 Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists |
| 08/29/2002 | WO2001062301A3 Imaging agents for diagnosis of parkinson's disease |
| 08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120149 Substituted hydrazine derivatives |
| 08/29/2002 | US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 08/29/2002 | US20020120146 Substituted 3-(piperidin-1-ylmethyl)cyclopentylamines, useful as modulators of the chemokine receptors CCR-5 and/or CC R-3. |
| 08/29/2002 | US20020120145 Inhibiting farnesyl protein transferase. |
| 08/29/2002 | US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 08/29/2002 | US20020120007 Benzamide inhibitors of factor Xa |
| 08/29/2002 | US20020119992 Anticoagulants |
| 08/29/2002 | US20020119988 Modulators of TNF-alpha signaling |
| 08/29/2002 | US20020119981 Novel N-substituted urea inhibitors of farnesyl-protein transferase |
| 08/29/2002 | US20020119980 Antihistamines, antiallergens |
| 08/29/2002 | US20020119979 Cancer therapy |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119972 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| 08/29/2002 | US20020119971 Antiinflammatory agents; skin disorders; central nervous system disorders |
| 08/29/2002 | US20020119968 Protease inhibitor |
| 08/29/2002 | US20020119963 Fertility; antidiabetic agents |
| 08/29/2002 | US20020119962 Novel urea compounds, compositions and methods of use and preparation |
| 08/29/2002 | US20020119960 Drug resistance therapy |
| 08/29/2002 | US20020119957 Novel post-amadori inhibitors of advanced glycation reactions |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | DE10107683A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 08/29/2002 | CA2453078A1 2-thio-substituted imidazole derivatives and their use in pharmacy |
| 08/29/2002 | CA2442742A1 Quinazoline derivatives |
| 08/29/2002 | CA2439898A1 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 08/29/2002 | CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | CA2434648A1 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 08/28/2002 | EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 08/28/2002 | EP1233949A2 5-substituted arylpyrimidines |
| 08/28/2002 | EP1233945A1 Heterocyclic ketone and thioester compounds and uses |
| 08/28/2002 | EP1233943A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 08/28/2002 | EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/28/2002 | EP1233769A1 Novel compounds |
| 08/28/2002 | EP1140898B1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |